Regardless of your purpose be it performance enhancement, TRT or a full blown HRT program you will be very hard pressed to find a better testosterone than Testosterone-Cypionate. In the world of TRT most will find 200mg every 7-10 days to be fairly common place and generally speaking about as high as you’ll ever go but of course in performance enhancing doses will necessarily be much higher. For the performance enhancer minimal dosing will generally be in the 400mg-500mg per week range and most commonly split into two even doses twice per week; for example, for 400mg total per wee k you might administer the hormone at 200mg on Monday and 200mg on Thursday continuing such a schedule until your total duration is complete.
For many 500mg per week will be as high as they ever need to go but in more hardcore circles it is not uncommon for doses to reach levels of 1,000mg per week and at extreme elite levels, especially in competitive bodybuilding they can go much higher. Keep in mind, while the benefits of use will increase as the dose does so will the potential and probability of adverse effects. There is a strong risk to reward ratio at play and in the end you are the only one who can determine how far you want to go with that. Yes, absolutely anabolic steroids and especially those of a pure testosterone nature such as Testosterone-Cypionate can be used safely and effectively but responsible use will always prove to be the ultimate key.
Part of responsible use will always include what is known as a Post Cycle Therapy (PCT) plan in order to normalize the body after use has been discontinued. Recall, the use of such hormones as Testosterone-Cypionate will suppress natural testosterone production but natural production will begin again once use is discontinued; however, such production will not begin instantly and there are things we can do to speed up the process. The sooner we get our natural production back up and running the more progress we made through our anabolic steroid use will be kept but most importantly our overall health will be protected; recall yet again, testosterone is essential to our health. This is where a good PCT plan comes in and it is by this plan we can stimulate natural production to begin; common supplemental items often include SERM’s such as Nolvadex and Clomid as well as the hormone hCG .
Testosterone, like many anabolic steroids, was classified as a controlled substance in 1991. Testosterone is administered parenterally in normal and delayed-release (depot) forms. In September 1995, the FDA approved testosterone transdermal patches (Androderm), and many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA-approved in July 2003; Striant is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation of testosterone (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA refused approval for Intrinsa in 2004 stating that more data regarding safety, especially in relation to cardiovascular and breast health, were required.
The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) medication guide for Testosterone. For Testosterone Undecanoate, REMS includes elements to assure safe use and implementation system . For additional information: /REMS
US BOXED WARNINGS :
Pulmonary Oil Microembolism (POME) Reactions And Anaphylaxis :
-Serious POME reactions, involving urge to cough, dyspnea, throat tightening, chest pain, dizziness, and syncope; and episodes of anaphylaxis, including life-threatening reactions, have been reported to occur during or immediately after the administration of testosterone undecanoate injection. These reactions can occur after any injection of testosterone undecanoate during the course of therapy, including after the first dose.
-Following each injection of testosterone undecanoate observe patients in the healthcare setting for 30 minutes in order to provide appropriate medical treatment in the event of serious POME reactions or anaphylaxis.
Secondary Exposure To Topical Testosterone :
-Virilization has been reported in children who were secondarily exposed to topical testosterone products.
-Children should avoid contact with unwashed or unclothed application sites in men using testosterone topical.
-Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
Safety and efficacy have not been established in patients younger than 18 years.
Testosterone Enanthate and Testosterone Implant are indicated for delayed puberty in adolescent patients.
Testosterone Cypionate: Safety and efficacy have not been established in patients younger than 12 years.
Consult WARNINGS section for additional precautions.